Clenbuterol
- Push50
- Posts: 275
- Joined: Thu Apr 29, 2021 6:35 pm
Clenbuterol
Clenbuterol (Clen)
History: Used medially as a bronchodilator and decongestant, Clen is sometimes prescribed to those with asthma as breathing aide.
Method of Administration: Clen is administered in oral form.
Drug Class: Beta 2 agonist.
Primary Use: Clenbuterol has only one primary use in the BB’ing community…fat loss. While it has been purported by some to build muscle, any anabolism associated with this drug is mild, making it ill-suited for this purpose. However, what clen lacks in the muscle building department, it more than makes up for it with its potent thermogenic effect. To this end, Clen is best employed as a pre-contest agent or at any other time rapid fat loss is desired. Over the last decade, it has become a popular practice to use Clen in-between cycles as a form of post-cycle therapy, with the intention of sparing muscle tissue and minimizing bodyfat gain at a time when one’s hormonal environment is generally sub-par. While there is some merit to this practice, one must consider whether this application is ideal for their circumstances. Those who choose to implement Clen into their program need to utilize discretion, as indiscriminate use can lead to overdose. Still, when used responsibly, clen is a relatively safe & effective fat loss drug, which is useful in helping to shed that last layer of stubborn bodyfat; revealing razor-sharp muscularity in the process.
Anabolic-Androgenic Ratio: N/A
Aromatizable: No
Progestagenic Activity: No
Methylated: No
Standard Dosing Range and Cycle Length: Clenbuterol is most commonly dosed at 40-120 mcg per day for a period of 2-8 weeks, although it is wise to start off at 20-30 mcg per day in order to assess tolerance. If one chooses to utilize this drug for more then 2-3 weeks consecutively, it must be used in combination with a drug such as Ketotifin, in order to prevent down-regulation of beta 2 receptors.
Frequency of Administration: Daily use; administered in a single daily dose.